Single Pill Regimen Leads to Better Adherence and Clinical Outcome in Daily Practice in Patients Suffering from Hypertension and/or Dyslipidemia: Results of a Meta-Analysis-Reference-Cited by-同舟云学术

Single Pill Regimen Leads to Better Adherence and Clinical Outcome in Daily Practice in Patients Suffering from Hypertension and/or Dyslipidemia: Results of a Meta-Analysis

Published:2020-03-26 Issue:2 Volume:27 Page:157-164
ISSN:1120-9879
Container-title:High Blood Pressure & Cardiovascular Prevention
language:en
Short-container-title:High Blood Press Cardiovasc Prev

Author:

Weisser Burkhard^ORCID,Predel Hans-Georg,Gillessen Anton,Hacke Claudia,vor dem Esche Johannes,Rippin Gerd,Noetel Andrea,Randerath Olaf

Funder

APONTIS Pharma GmbH & Co. KG

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine,Internal Medicine

Link

http://link.springer.com/content/pdf/10.1007/s40292-020-00370-5.pdf

Reference28 articles.

1. Destatis.de [homepage on the internet]. Wiesbaden: statistisches bundesamt gesundheit. Todesursachen in Deutschland 2015. Fachserie b12: 2017. http://www.Destatis.de. Accessed 18 Jul 2018.

2. Kostis JB. The importance of managing hypertension and dyslipidemia decrease cardiovascular disease. Cardiovasc Drugs Ther. 2007;21:297–309.

3. Rki.de [homepage on the internet]. Berlin: Robert Koch Institut. Faktenblatt zu GEDA 2012: Ergebnisse der Studie »Gesundheit in Deutschland aktuell 2012«, Fettstoffwechselstörungen: 2017. http://www.rki.de. Accessed 18 Jul 2018.

4. Neuhauser H, Thamm M, Ellert U. Blutdruck in Deutschland 2008–2011. Bundesgesundheitsbl. 2013;56:795–801.

5. Rki.de. [homepage on the internet]. Berlin: Robert Koch Institut. Der Blutdruck in Deutschland ist gesunken, das Präventionspotential bleibt aber hoch. Epidemiologisches Bulletin 5/201533-40 2017. http://www.rki.de. Accessed 18 Jul 2018.

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Glutamatergic Modulators for Major Depression from Theory to Clinical Use;CNS Drugs;2024-08-16

2. Cost-effectiveness analysis comparing single-pill combination of perindopril/amlodipine/indapamide to the free equivalent combination in patients with hypertension from an Italian national health system perspective;Expert Review of Pharmacoeconomics & Outcomes Research;2024-06-14

3. Use of fixed-dose combinations for cardiovascular indications from 2018 to 2023: a nationwide population-based study;Journal of Hypertension;2024-06-11

4. High burden of non-adherence to blood pressure-lowering medications: meta-analysis of data from over 34,000 adults with hypertension in Sub-Saharan Africa;2024-05-29

5. Pharmacokinetics of a Fixed-Dose Combination Product of Amlodipine, Losartan, Ezetimibe, and Rosuvastatin and Its Comparison with Co-administration of Four Individual Components in Healthy Participants;Drugs in R&D;2024-05-22